Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

830
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
830
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

521
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
521
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

569
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
569
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

522
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
522

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Objective measurement of oral function in adults with spinal muscular atrophy.

Orphanet journal of rare diseases·2023
Same author

The impact of apraxia and neglect on early rehabilitation outcome after stroke.

Neurological research and practice·2022
Same author

An analysis of the CatWalk XT and a composite score to assess neurofunctional deficits after photothrombosis in mice.

Neuroscience letters·2021
Same author

Aberrant frontostriatal connectivity in Alzheimer's disease with positive palmomental reflex.

European journal of neurology·2020
Same author

Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome.

European journal of neurology·2020
Same author

[Prevalence and characteristics of apraxic deficits after left and right hemisphere stroke].

Fortschritte der Neurologie-Psychiatrie·2020
Same journal

[Rare hereditary and acquired diseases with parkinson's syndrome].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Digital transformation in multiple sclerosis: Advances in diagnostics, monitoring and patient-centred care].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Dementia with Lewy bodies].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Impact of the PEPP reimbursement system and other developments on inpatient care of general psychiatry patients 2005 to 2022: a retrospective analysis].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[The pathology of the brain eating amoeba Naegleria fowleri].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Chronic vestibular syndromes: Correct diagnosis and treatment].

Fortschritte der Neurologie-Psychiatrie·2026
See all related articles

Related Experiment Video

Updated: Mar 10, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

5.0K

[Chronic Inflammatory Demyelinating Polyneuropathy].

M Balke1, G Wunderlich1, A Brunn2

  • 1Klinik und Poliklinik für Neurologie, Universitätsklinikum Köln.

Fortschritte Der Neurologie-Psychiatrie
|December 13, 2016
PubMed
Summary
This summary is machine-generated.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disorder affecting nerves. Diagnosis involves symptoms, nerve tests, and CSF analysis, with imaging showing promise for identifying this progressive condition.

More Related Videos

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.5K
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

10.2K

Related Experiment Videos

Last Updated: Mar 10, 2026

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

5.0K
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.5K
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

10.2K

Area of Science:

  • Neurology
  • Immunology
  • Clinical Medicine

Background:

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder characterized by progressive or relapsing nerve damage.
  • It presents with varied symptoms, including symmetrical weakness and sensory loss, but atypical forms with rapid onset or asymmetrical deficits are increasingly recognized.

Purpose of the Study:

  • To summarize the current understanding of Chronic inflammatory demyelinating polyneuropathy (CIDP) diagnosis and treatment.
  • To highlight the evolving diagnostic landscape and therapeutic options for CIDP.

Main Methods:

  • Review of clinical presentations, diagnostic criteria, and therapeutic strategies for CIDP.
  • Inclusion of information on emerging diagnostic tools like MRI and nerve ultrasound.
  • Discussion of established and advanced treatment modalities.

Main Results:

  • CIDP diagnosis relies on clinical symptoms, electrophysiological findings, and cerebrospinal fluid analysis.
  • Nerve biopsy can confirm inflammation in challenging cases.
  • Imaging techniques like MRI and nerve ultrasound are emerging as valuable diagnostic aids.

Conclusions:

  • CIDP is a heterogeneous autoimmune neuropathy requiring a multi-faceted diagnostic approach.
  • Standard treatments include immunoglobulins, steroids, and plasmapheresis.
  • Immunosuppressants and biologics offer alternatives for refractory cases.